Is Direxion mRNA ETF halal to invest in?

As of September 2026, Direxion mRNA ETF MSGR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Direxion mRNA ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Direxion mRNA ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Direxion mRNA ETF updated?

The Shariah compliance status of Direxion mRNA ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Direxion mRNA ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Direxion mRNA ETF?

You can check the latest Shariah compliance status of Direxion mRNA ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Direxion mRNA ETF MSGR

MSGR Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Direxion mRNA ETF is classified as not halal.

NOT HALAL

Is Direxion mRNA ETF Halal?

Shariah Compliance Analysis of MSGR ETF

US Equity Health Care

No. As of September 2026, Direxion mRNA ETF (MSGR) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Direxion mRNA ETF does not pass Musaffa's business and financial screening criteria.

MSGR was created on 2021-12-09 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 3.02m in AUM and 24 holdings. MSGR tracks a market-cap-weighted index of companies from the US, Canada, and Europe that contribute to the development and application of messenger RNA (mRNA) technology.

Direxion mRNA ETF (MSGR) Chart

Key Statistics of Direxion mRNA ETF (MSGR)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
92.99%
Other
7.01%

FAQ's for Direxion mRNA ETF (MSGR)

As of September 2026, Direxion mRNA ETF MSGR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Direxion mRNA ETF using these criteria to determine its compliance status.
The Shariah compliance status of Direxion mRNA ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Direxion mRNA ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.